The Enteroendocrine System in Obesity.
Quick Facts
What This Study Found
The enteroendocrine system is not markedly disrupted by high BMI or obesogenic diets.
Key Numbers
How They Did This
The study reviews the role of gut hormones in regulating digestion and insulin secretion.
Why This Research Matters
Understanding how the enteroendocrine system functions in obesity can lead to new treatments for weight loss and related health conditions.
What This Study Doesn't Tell Us
The study is primarily a review and may not include new experimental data.
Trust & Context
- Original Title:
- The Enteroendocrine System in Obesity.
- Published In:
- Handbook of experimental pharmacology, 274, 109-129 (2022)
- Authors:
- Miedzybrodzka, Emily L, Reimann, Frank(3), Gribble, Fiona M(3)
- Database ID:
- RPEP-06369
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06369APA
Miedzybrodzka, Emily L; Reimann, Frank; Gribble, Fiona M. (2022). The Enteroendocrine System in Obesity.. Handbook of experimental pharmacology, 274, 109-129. https://doi.org/10.1007/164_2022_582
MLA
Miedzybrodzka, Emily L, et al. "The Enteroendocrine System in Obesity.." Handbook of experimental pharmacology, 2022. https://doi.org/10.1007/164_2022_582
RethinkPeptides
RethinkPeptides Research Database. "The Enteroendocrine System in Obesity." RPEP-06369. Retrieved from https://rethinkpeptides.com/research/miedzybrodzka-2022-the-enteroendocrine-system-in
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.